Skip to main content
. 2020 Aug;32(4):516–529. doi: 10.21147/j.issn.1000-9604.2020.04.09

2. Overall and subgroup analysis of medical and non-medical expenditure for liver cancer diagnosis and treatment per case.

Variables Medical expenditure (CNY) Non-medical
expenditure (CNY)
Overall expenditure
Value (CNY) Statistics* P*
*, Two-sample Student test after logarithm transition for two groups comparative analysis, analysis of variance (ANOVA) test after logarithm transition for more than two groups comparative analysis.
Total 48,612 4,608 53,220
Hospital type
 General 40,570 3,773 44,343 −5.56 <0.001
 Specialized 51,211 4,878 56,089
Age at diagnosis (year)
 <45 52,605 4,880 57,485 2.65 0.047
 45−54 50,595 4,779 55,374
 55−64 46,474 4,745 51,219
 ≥65 46,318 3,967 50,285
Gender
 Male 49,294 4,630 53,924 1.28 0.201
 Female 46,018 4,525 50,543
Education
 Primary school or below 43,080 3,597 46,677 23.21 <0.001
 Junior high school 45,280 3,994 49,274
 Senior high school 52,873 5,381 58,254
 Undergraduate or over 67,373 8,073 75,446
Occupation
 Farmer 42,643 3,702 46,345 9.55 <0.001
 Enterprise or company employee/worker 49,453 4,508 53,961
 Self-employed or unemployed 48,402 4,738 53,140
 Retiree 56,053 7,255 63,308
 Staff in institution/civil servant 67,797 5,794 73,591
 Other 45,513 4,696 50,209
Health-care insurance type
 Urban employees basic medical insurance 53,250 5,286 58,536 8.49 <0.001
 Urban residents basic medical insurance 51,452 4,798 56,250
 New rural cooperative medical scheme 43,515 3,933 47,448
 Commercial insurance 20,876 1,345 22,221
 Self-financed 44,158 4,345 48,503
 Other 55,604 5,513 61,117
Previous year household income
 <20,000 40,684 4,212 44,896 8.57 <0.001
 20,000−39,999 45,170 4,390 49,560
 40,000−69,999 50,461 4,814 55,275
 ≥70,000 53,402 4,720 58,122
Clinical stage
 I 48,644 4,173 52,817 1.56 0.198
 II 46,616 4,261 50,877
 III 46,319 4,359 50,678
 IV 49,063 5,026 54,089
Therapeutic regimen
 Surgery 57,641 4,970 62,611 19.82 <0.001
 Chemotherapy 45,773 4,652 50,425
 Surgery and postoperative chemotherapy 55,042 5,070 60,112
 Symptomatic treatment 44,837 4,644 49,481
 Concurrent chemoradiotherapy 50,892 4,524 55,416
 Radiotherapy 56,251 4,943 61,194
 Neoadjuvant chemoradiotherapy and surgery 42,449 4,747 47,196
Pathological type
 Hepatocellular carcinoma 50,937 4,592 55,529 0.96 0.338
 Other 48,143 4,213 52,356